Myasthenia Gravis in Dogs

Myasthenia gravis is a failure of communication between nerve and muscle. The nerve sends the signal, the muscle never receives it, and the dog goes weak.

It is worth understanding for one specific reason beyond the weakness itself. Myasthenia gravis is the most common identified cause of megaesophagus in dogs, and unlike most of the other causes, it can go into remission.

What Goes Wrong

Where a nerve meets a muscle there is a gap. The nerve releases acetylcholine across it, and receptors on the muscle side catch that signal and contract the muscle.

In acquired myasthenia gravis the immune system produces antibodies against those receptors. The acetylcholine still arrives. There is progressively less on the other side to receive it. The muscle fires weakly or not at all, and the more it is used the worse it gets, which is why the classic sign is weakness that appears with exercise and improves with rest.

A congenital form exists in a few breeds, where the receptors are deficient from birth rather than attacked later. It is rare. Most cases seen in practice are acquired.

Three Forms, and They Look Nothing Alike

According to Today's Veterinary Practice, the three forms are focal, generalised and fulminant.

Focal disease is largely confined to the muscles of the mouth, throat and oesophagus. The dog walks normally and has no obvious weakness. What it has is regurgitation, difficulty swallowing, a changed bark or excessive drooling. This is the form that gets missed, because nothing about it looks neurological.

Generalised disease adds limb weakness to that picture, along with megaesophagus. The dog tires on a walk it used to manage, and the weakness worsens the longer it goes on.

Fulminant disease is the acute severe version. It comes on fast, the weakness is profound, and it can progress to the point where the muscles of respiration fail and the dog needs ventilatory support. It is an emergency.

Why It Causes Megaesophagus

The oesophagus in a dog is skeletal muscle along its whole length, which is not true in people. That means it depends on the same nerve to muscle signalling that the legs do, and it fails the same way.

When that muscle stops contracting properly the tube stretches and stops moving food. The result is megaesophagus, and myasthenia gravis accounts for up to 30 percent of cases.

The relationship runs in both directions, which is the practically useful part. A dog presenting with megaesophagus should be tested for myasthenia gravis. A dog diagnosed with myasthenia gravis should have chest radiographs, because it may have a dilated oesophagus that nobody has looked for and that changes how it must be fed immediately.

The Test

The diagnosis rests on a blood test measuring acetylcholine receptor antibodies, run by radioimmunoprecipitation assay.

It is a good test. Around 98 percent of dogs with generalised myasthenia gravis are positive on it, and roughly 2 percent are seronegative, meaning they have the disease with a normal titre. That small false negative rate matters if the clinical picture is convincing and the result comes back clear, because it means the result does not close the question by itself.

Blood has to be drawn before starting any steroid treatment, since immunosuppression can suppress the titre and produce a negative result in a dog that genuinely has the disease.

Look for a mass at the same time

Acquired myasthenia gravis can be triggered by a tumour, most commonly a thymoma sitting in the front of the chest. Chest imaging is part of the workup rather than an optional extra, because removing the mass can resolve the myasthenia.

Treatment

The first line drug is pyridostigmine bromide, dosed at 0.5 to 3.0 mg/kg twice or three times daily and adjusted to response. It slows the breakdown of acetylcholine in the gap, so what signal still gets through has longer to work. It does not treat the underlying immune problem, it compensates for it.

Immunosuppression is used in some dogs and avoided in others, and the reason for the caution is aspiration. A dog with megaesophagus is already at high risk of pneumonia, and suppressing its immune system while it repeatedly inhales food is a difficult trade to make. That decision belongs with a neurologist rather than a general practice.

Where megaesophagus is present, the feeding routine is not a supporting measure. It is the main thing keeping the dog alive while the drugs are given time to work, and it means every meal taken with the front end raised and held there afterwards. A megaesophagus chair is what makes that practical for a dog large enough that holding it by hand four times a day is not realistic.

Remission Is Real, and the Figures Disagree

This is the part worth knowing, and the published numbers are not consistent with each other.

The Comparative Neuromuscular Laboratory at UC San Diego reports that most dogs enter clinical remission if they survive the acute phase, with an average time to remission of six to eight months, some faster and some taking over a year.

A clinical series reported in Today's Veterinary Practice found a less optimistic distribution: 31 percent of patients reached clinical remission, 15 percent were clinical responders, 26 percent improved with therapy, and 29 percent showed no improvement.

Both are worth reading together rather than picking the kinder one. Remission happens often enough to be a genuine goal, it is not the default outcome, and the single largest variable in whether a dog gets there is whether it survives the first few months.

What Actually Kills These Dogs

Not the weakness. Approximately 50 percent of dogs diagnosed with acquired myasthenia gravis die of aspiration pneumonia or respiratory paralysis.

That figure reframes the whole management problem. The disease is often survivable and frequently remits, and the thing standing between a dog and that outcome is usually food going down the wrong way in the months before the treatment takes effect.

Coughing, fever, fast or laboured breathing and sudden lethargy are an emergency in these dogs rather than something to watch overnight. Our guide to aspiration pneumonia in dogs covers what recognition and treatment involve.

Breeds Seen More Often

Acquired myasthenia gravis is over represented in German shepherds, golden retrievers, Labrador retrievers, Akitas, Newfoundlands and Great Danes.

There is also an age pattern worth knowing. Cases cluster at two points, in young adult dogs and again in older dogs, rather than spreading evenly across life. A young dog going weak on walks is not too young for this diagnosis.

What to Ask For

If your dog regurgitates, tires abnormally on walks, has a changed bark or drools more than it used to, the specific request is an acetylcholine receptor antibody titre, chest radiographs, and imaging of the front of the chest to look for a mass.

Those three things together either find this disease or rule it out, and they are worth pushing for, because a dog with megaesophagus and no cause identified is being managed for a symptom while a treatable disease goes unaddressed.

For the dogs that do have a dilated oesophagus, the Whisker Bark Bailey chair covers the feeding side of that management, which is the part that keeps the dog alive long enough for the rest of the treatment to matter.